For immediate release
Circassia Pharmaceuticals plc
Annual Report and Accounts for the year ended 31 December 2018 and Notice of 2019 Annual General Meeting
14 May 2019
Circassia Pharmaceuticals plc announces that its Annual Report and Accounts for the year ended 31 December 2018 and Notice of 2019 Annual General Meeting have been published on the Company's website: www.circassia.com. Additionally, these documents have been posted, or otherwise made available, to shareholders.
The Annual General Meeting will be held at 12.00 midday on Friday 7 June 2019 at the Company's offices: Northbrook House, Robert Robinson Avenue, Oxford, OX4 4GA.
Contacts
Circassia
Steven Harris, Chief Executive Officer Tel: +44 (0) 1865 405 560
Julien Cotta, Chief Financial Officer
Rob Budge, Corporate Communications
Peel Hunt (Nominated Adviser and Joint Broker)
James Steel / Dr Christopher Golden Tel: +44 (0) 20 7418 8900
Numis Securities (Joint Broker)
James Black / Freddie Barnfield Tel: +44 (0) 20 7260 1000
FTI Consulting
Simon Conway / Ciara Martin Tel: +44 (0) 20 3727 1000